Navigation Links
Most Cancer Treatment Studies Aren't Published, Study Finds
Date:9/15/2008

Concern Raised about 'Cancer Publication Bias'

DURHAM, N.C., Sept. 15 /PRNewswire/ -- Less than 20 percent of registered clinical trials of cancer treatment are eventually published in medical journals, according to a study published online today by the journal "The Oncologist."

(LOGO: http://www.newscom.com/cgi-bin/prnh/20080627/CLF051LOGO )

Drs. Scott Ramsey and John Scoggins of University of Washington and Fred Hutchinson Cancer Research Center, Seattle, searched the National Institutes of Health's ClinicalTrials.gov registry to identify 2,028 registered research studies of cancer treatment. Major medical journals now require that all studies considered for publication be registered in a publicly accessible database like ClinicalTrials.gov .

A subsequent search of the National Library of Medicine's PubMed database showed that just 17.6 percent of the trials were eventually published in peer-reviewed medical journals. "We find that less than 1 in 5 completed trials registered since the inception of ClinicalTrials.gov are listed in the registry or PubMed as published manuscripts," Drs. Ramsey and Scoggins write.

The publication rate was particularly low for "industry-sponsored" studies, such as those funded by pharmaceutical companies -- just 5.9 percent, compared to 59 percent for studies sponsored by collaborative research networks.

Of published studies, nearly two-thirds had "positive" results-the study treatment worked as hoped. The remaining one-third had "negative" results -- the outcome was disappointing or did not merit further consideration of the tested treatment.

This finding raises concern about "publication bias" in cancer treatment trials. The researchers suspect that the rate of negative results is much higher in the studies that have gone unpublished. Drs. Ramsey and Scoggins write, "It is likely that
'/>"/>

SOURCE AlphaMed Press
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Novel Technology Breaks Through Cancer Pain
8. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
9. Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013  Team Health Holdings Inc. ... largest suppliers of outsourced healthcare professional staffing and administrative ... the United States , today announced that ... Deutsche Bank Healthcare Conference held on May 29, 2013 ... at 8:00 AM eastern time.  Interested investors and other ...
(Date:5/22/2013)... , May 22, 2013 Attorney Advertising ... claims on behalf of purchasers of the securities ... (NasdaqGS: AMAG -News).  The investigation focuses on whether ... laws. On May 22, 2013, Shares ... trading after the company announced in regulatory filing ...
(Date:5/22/2013)... 2013   Accuray Incorporated (Nasdaq: ... to present at the 2013 Jefferies Global Healthcare Conference ... June 6, 2013 at 1:30 p.m. EDT/10:30 a.m. PDT. ... be available online from the Investor Relations page of ... webcast replay of the presentation will begin approximately one ...
Breaking Medicine Technology:Team Health Holdings Inc. to Present at the 38th Annual Deutsche Bank Healthcare Conference 2Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2
(Date:5/22/2013)... (PRWEB) May 22, 2013 Dr. Andrew Satlin ... painful scalpel surgery with the Laser Assisted New Attachment Procedure ... raising awareness about the connections between gum disease and stroke. ... in the United States today, and is linked to an ... bacteria found in the infected gum pockets. , Periodontal ...
(Date:5/22/2013)... May 22, 2013 Hosted by the ... free dental clinic provided more than $1.6 million in ... 18-19 in San Jose. , The California Dental ... clinic to provide free dental services and oral health ... is the third clinic held by CDA and CDAF ...
(Date:5/22/2013)... shows there is a gender gap when it comes ... one that does not appear to exist in children ... higher levels of self-regulation than boys. Self-regulation is defined ... follow directions, and persist on a task. It has ... past studies by Oregon State University researchers. , ...
(Date:5/22/2013)... ID (PRWEB) May 22, 2013 Bodybuilding.com ... This Memorial Day (May 27, 2013) Bodybuilding.com will be donating ... of the amount. , “We are extremely grateful for ... the Armed Forces,” said Ryan DeLuca, CEO and founder of ... heroes who have sacrificed so much. Hire Heroes USA is ...
(Date:5/22/2013)... ARBORA University of Michigan study challenges previous research ... Baseball. , The study, a collaboration between researchers ... Florida, looks deeper into the controversial argument over ... strikes for pitchers of the same race. It ... said Jason Winfree, associate professor of sport management ...
Breaking Medicine News(10 mins):Health News:For Stroke Awareness Month, Dr. Andrew Satlin is Raising Awareness of the Connections Between Gum Disease and Stroke and Offers Encino, CA Laser Gum Surgery for Treatment 2Health News:Two-day San Jose Dental Clinic Provides More Than $1.6 Million in Care 2Health News:'Boys will be boys' in US, but not in Asia 2Health News:'Boys will be boys' in US, but not in Asia 3Health News:In the Spirit of Memorial Day, Bodybuilding.com is Donating a Portion of Their Sales to Hire Heroes 2Health News:U-M study challenges notion that umpires call more strikes for pitchers of same race 2
... CHERRY HILL, N.J., May 19 Nuvilex, Inc. (OTC ... with a portfolio of aesthetics, dermatology, environmental and nutraceutical ... will be held on Tuesday, June 2, 2009 at ... call, please dial 1-877-407-4018 (U.S.) and 1-201-689-8471 (international). ...
... athlete,s foot sufferers and parents.KENILWORTH, N.J., May 19 ... SGP ) today announced the arrival ... treatment of athlete,s foot. TINACTIN CHILL is available ... spray.(Photo: http://www.newscom.com/cgi-bin/prnh/20090519/NY19030 )To view the ...
... Optimizing CHO Performance" inside the BIO Process Product Zone on May ... ... CO (PRWEB) May 19, 2009 -- Amidst the sea of people, ... InVitria, a cell culture media supplement company that provides performance enhancing ...
... patient with help from GI specialists, GI Monitor, an ... (IBD) Crohn,s and Ulcerative Colitis to track their symptoms ... N.J., May 19 WellApps, Inc. launched an iPhone ... Colitis provide accurate symptom data to their doctors for ...
... LONDON, May 19 Regulatory processes differ across ... a pressing need to integrate the regulatory environment ... Diverse regulations impact drug launches as less price ... longer in regulated markets. The pharmaceutical industry, along ...
... Campaign for Bay Harbor Podiatry Group,s Revolutionary Laser Treatment ... Bob Gold & Associates, Inc ., a Southern ... a new addition to its client roster, ... practice that has provided cutting-edge medical treatments and personalized ...
Cached Medicine News:Health News:Nuvilex, Inc. Announces Monthly Investor Conference Call 2Health News:Video: Schering-Plough Introduces TINACTIN(R) CHILL, a Line of Antifungal Products Geared Specifically to Young Males 2Health News:InVitria to Present at BIO 2009 International Convention in Atlanta 2Health News:IBD Patient Launches iPhone Application to Help Doctors Treat Crohn's and Ulcerative Colitis 2Health News:Transatlantic Regulatory Integration of Drug Approval Process Vital for the Global Pharmaceutical Industry, Notes Frost & Sullivan 2Health News:Transatlantic Regulatory Integration of Drug Approval Process Vital for the Global Pharmaceutical Industry, Notes Frost & Sullivan 3Health News:Transatlantic Regulatory Integration of Drug Approval Process Vital for the Global Pharmaceutical Industry, Notes Frost & Sullivan 4Health News:Bob Gold & Associates Steps Up as Marketing & PR Agency for Bay Harbor Podiatry Group 2
... a spill-proof design and effective output, even ... All medical nebulizers are free-standing for easy ... are available., ,All Portex® medication nebulizer ... nebulizers feature consistently fine misting and the ...
... well as humidification, try Flo-Mist™., ,Flo-Mist™, ... continuous medication nebulizer (CMN), engineered to deliver ... ml reservoir and jet flow design allow ... medication delivery at 25 ml/hr. Particles are ...
Infant Nebulizer Kit W/Misty-Nebulizer 30/CS CE Mark Only...
... and Respiratory Products, ,Westmed designs, manufacturers ... Anesthesia and Respiratory professionals. Our mission is ... the clinician's ability to deliver quality medical ... bottom line. , ,Our web site ...
Medicine Products: